Aortic Repair Devices – Market Insights – United States

The US aortic repair device market will grow moderately during upcoming years, driven by the uptake of innovative stent grafts and the positive clinical evidence that supports their adoption. The switch from surgical toward endovascular and hybrid approaches will be mainly driven by the increasing availability of aortic stent grafts that allow treatment of more complex thoracic aortic lesions, as well as treatment of indications that are currently underpenetrated. Given the premium prices of these devices, their adoption will also positively impact market growth.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aortic repair devices in the US from 2019 through 2034.

The rising adoption of endovascular and hybrid treatments for complex thoracic aortic anatomies is a key driver of the US aortic repair device market.

What are the main factors contributing to the increasing preference for endovascular and hybrid treatments over traditional surgical options for these indications?

How will the anticipated launch of new devices and the outcomes of ongoing clinical trials influence the growth trajectory of the overall aortic repair device market?

Which manufacturers are best positioned to benefit from current trends? Are any emerging products expected to be launched in the coming years?

The potential entry of innovative devices is expected to address unmet needs in the aortic repair device market.

Once introduced, how will aortic stent grafts for the ascending aorta impact procedural trends?

Will hybrid endografts for the thoracoabdominal aorta drive increased adoption of hybrid procedures in this anatomy?

To what extent will these devices reshape the competitive landscape in the coming years?

Standardized patient monitoring and management programs are essential to ensure the long-term safety and effectiveness of aortic repair procedures.

What are the key findings from clinical trials and retrospective observational studies regarding the long-term outcomes of endovascular aortic repair?

How will these findings influence patient selection and clinical decision-making?

What initiatives are companies and regulatory bodies undertaking to establish the long-term safety and effectiveness of aortic stent grafts?

To what extent will head-to-head device comparisons drive market share shifts in coming years?